Robert Carey is Director of Beyond Air, Inc.. Currently has a direct ownership of 3.08 Million shares of XAIR, which is worth approximately $1.66 Million. The most recent transaction as insider was on Nov 19, 2021, when has been sold 12,000 shares (Common Stock) at a price of $14.1 per share, resulting in proceeds of $169,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.08M
0% 3M change
151.14% 12M change
Total Value Held $1.66 Million

Robert Carey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2021
BUY
Open market or private purchase
$169,200 $14.1 p/Share
12,000 Added 2.37%
493,418 Common Stock
Jun 17 2021
BUY
Open market or private purchase
$1,876,000 $5.36 p/Share
350,000 Added 42.1%
481,418 Common Stock
Mar 04 2021
BUY
Open market or private purchase
$96,900 $5.7 p/Share
17,000 Added 11.45%
131,418 Common Stock
Feb 18 2021
BUY
Open market or private purchase
$100,050 $6.67 p/Share
15,000 Added 11.59%
114,418 Common Stock

Also insider at

HZNP
Horizon Therapeutics Public Ltd Co Healthcare
SGMO
SANGAMO THERAPEUTICS, INC Healthcare
RC

Robert Carey

Director
Dublin, L2

Track Institutional and Insider Activities on XAIR

Follow Beyond Air, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XAIR shares.

Notify only if

Insider Trading

Get notified when an Beyond Air, Inc. insider buys or sells XAIR shares.

Notify only if

News

Receive news related to Beyond Air, Inc.

Track Activities on XAIR